Drug Shortage Report for TEGRETOL SUSPENSION
| Report ID | 64629 |
| Drug Identification Number | 02194333 |
| Brand name | TEGRETOL - SUS 100MG/5ML |
| Common or Proper name | TEGRETOL SUSP 100MG/5ML 450ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 100MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 450 ML |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2018-10-19 |
| Actual start date | 2018-10-19 |
| Estimated end date | 2019-12-11 |
| Actual end date | 2018-12-17 |
| Shortage status | Resolved |
| Updated date | 2018-12-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2018-12-18 | French | Compare |
| v9 | 2018-12-18 | English | Compare |
| v8 | 2018-11-16 | French | Compare |
| v7 | 2018-11-16 | English | Compare |
| v6 | 2018-11-01 | English | Compare |
| v5 | 2018-11-01 | French | Compare |
| v4 | 2018-11-01 | English | Compare |
| v3 | 2018-10-20 | English | Compare |
| v2 | 2018-10-17 | French | Compare |
| v1 | 2018-10-17 | English | Compare |
Showing 1 to 10 of 10